Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Kiora Pharmaceuticals, Inc. (KPRX) had Normalized Pre-Tax Income of $-2.07M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.19M |
|
-- |
|
-- |
|
$2.33M |
|
$-2.33M |
|
$0.26M |
|
$-2.07M |
|
|
Normalized Pre-Tax Income |
$-2.07M |
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.19M |
|
$-2.33M |
|
$-2.33M |
|
4.22M |
|
4.22M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$27.11M |
|
$0.01M |
|
$6.91M |
|
$34.02M |
|
$5.27M |
|
-- |
|
$5.04M |
|
$10.32M |
|
$23.70M |
|
$17.01M |
|
$23.70M |
|
3.00M |
|
| Cash Flow Statement Financials | |
$-2.70M |
|
$2.67M |
|
$0.00M |
|
$3.80M |
|
$3.78M |
|
$-0.02M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.25% |
|
-12.89% |
|
-6.45% |
|
-9.25% |
|
$7.90 |
|
$-0.64 |
|
$-0.64 |
|